Penko S.
- Country
- Bulgaria
- Department
- Clinic of Neurology Diseases
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- A Double-blind, Randomized, Active-controlled, Parallel-group, Phase 1/3 study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients with Relapsing-remitting Multiple Sclerosis.
- Evaluation of Ofatumumab Efficacy and Patient-Reported Outcomes in Relapsing Multiple Sclerosis Patients Transitioning from Fumarate-Based Therapies or Fingolimod
Data & Insights
Has run more than one trial at 245 of 478 partner sites.
Specializations
Multiple Sclerosis Research
The investigator specializes in various forms of multiple sclerosis, with particular emphasis on studying therapeutic approaches for both relapsing and progressive forms of the condition. Their research encompasses innovative treatments including ofatumumab, remibrutinib, and tolebrutinib.
- Relapsing Multiple Sclerosis (RMS)
- Primary Progressive Multiple Sclerosis (PPMS)
- Secondary Progressive Multiple Sclerosis
Neurological Conditions
The investigator's expertise extends to other neurological conditions, particularly focusing on drug-resistant epilepsy and seizure management. Their work includes evaluation of extended-release formulations for enhanced therapeutic outcomes in focal onset seizures.
- Refractory Partial Onset Epilepsy
- Focal Onset Seizures
- Central Nervous System Inflammation
Additional Therapeutic Areas
The investigator's research portfolio includes studies in inflammatory conditions and hematological disorders. Their work encompasses investigations in Crohn's Disease, axial spondyloarthritis, and myeloproliferative neoplasms.
- Inflammatory Bowel Disease
- Rheumatological Conditions
- Hematologic Malignancies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.